… AD and gives credence to the angiotensin hypothesis for AD. Converging evidence …
hypothesis of AD that continues to gain support. In the last two decades, the angiotensin hypothesis …

… lead to vascular disease. Indeed, recent clinical trials of ACE inhibitors have consistently …
class of agents in treating and preventing cardiovascular disease, with impressive reductions in …

… thereby preventing Charcot-… disease, and our hypothesis of cerebroprotection by AT2
receptor activation should be tested by a head-to-head comparison of an ARB with an ACE inhibitor…

… greater scope for disease prevention than any currently … This review explores the hypothesis
that angiotensin II (Ang II… clinical evidence that supports this hypothesis. It also discusses …

… to some extent can prevent metabolic disease. Furthermore, an … The primary effector hormone
of the RAS, angiotensin II, … Based on these observations, we hypothesize that an activated …

… in the development of hypertensive heart disease, congestive heart failure, and … ACE inhibitors
improved the morbidity and mortality rates of patients with various cardiovascular diseases…

… effect of lowering blood pressure on coronary artery disease. The assumption that coronary
events are not … heart failure as ACE inhibitors do not prevent or reverse fluid retention [4546]. …

… hypothesis may help explain the association between migraine and cardiovascular disease
… an important target in migraine prevention, further hypothesis testing and confirmation of the …

… and contribution to cardiovascular disease in general, and to … arm of the renin-angiotensin
system, which depends heavily … becomes a primary target for the prevention and treatment of …

… and separate enzymatic pathways for the production of bioactive angiotensin peptides. While
we intend to investigate this hypothesis further, our data may encourage others to provide …